Apex Innovative Sciences, Inc.   Report issue

For profit Phase 4
Founded: Marlton NJ United States (2019)
Status: No NME R&D (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Apex Innovative Sciences

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Apex Innovative Sciences, Inc. (0) Acquired (1)

buprenorphine (2 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 1